Novo Nordisk

Semiconductors

ASML Becomes Biggest Company in European History

Photo via Robin Utrecht/ANP/Newscom

A share price rally pushed ASML’s market cap to $668 billion on Wednesday, beating a European record set by Novo Nordisk in June 2024.

1 min read

Photo via Spencer Jones/GHI//UCG/Universal Images Group/Newscom

Healthcare

Lilly Follows Upbeat Trials for Cholesterol Shot with $4B M&A Spree

The highest dose of a single injection reduced cholesterol levels by 62% in patients, according to Eli Lilly’s recently published study.

2 min read
Photo via Stephane Lemouton/SIPA/Newscom

Artificial Intelligence

AI Drug Designer Isomorphic Details Lofty Plans for $2.1B in New Funding

Isomorphic previously raised $600 million in external funding last year, which was also led by NYC’s Thrive Capital.

1 min read
Photo via Michael Siluk/UCG/Universal Images Group/Newscom

Healthcare

Scoring 2 Million Prescriptions, Novo’s GLP-1 Pill Crushes Expectations

The pill era has ushered in a Wild-West-style land-grab for GLP-1 market share but the horizon seems to keep expanding.

2 min read

Artificial Intelligence

OpenAI Teams with Novo Nordisk to Speed Prescription Drug Development

Photo via Ritzau Scanpix/Sipa USA/Newscom

The move comes as OpenAI watches rival Anthropic make big enterprise splashes with its Claude Code and Mythos AI tools.

2 min read

Healthcare

Novo Nordisk Launches Suit to Knock Out Hims & Hers’ Weight Loss Knockoffs

Photo via Ritzau Scanpix/Sipa USA/Newscom

Novo’s Copenhagen-listed shares rose 5.2% on Monday. New York-listed shares in Hims & Hers, meanwhile, shed an Ozempic-like 16% in volume.

2 min read

M&A

Novo Nordisk’s $10 Billion Bid Ups the Ante in Bidding War for Obesity Biotech Metsera

Photo via Mads Claus Rasmussen/ZUMAPRESS/Newscom

Metsera on Tuesday called Novo Nordisk’s new $10 billion offer “superior” to rival Pfizer’s bid of $8 billion.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.